News


January 27, 2016:Kane Biotech Announces Private Placement Offering Read more...

January 08, 2016:Kane Biotech receives $240,000 from Warrant Exercise Read more...

January 05, 2016:Kane Biotech appoints new CFO and announces addition of Commercialization Team Resources, Sales Representation Agreement for U.S. Market Expansion, and Grant of Options Read more...

December 31, 2015:Kane Biotech Announces Issuance of Common Shares in Payment of Outstanding Interest Read more...

December 14, 2015:Kane Biotech Announces Amendments to Terms of Convertible Note and Warrants Read more...

Products


DispersinB® is the company's trademark for the wound care market, which contains a portfolio of wound care solutions. Read more...

Aledex® is the company's trademark for the medical device coating market, which is a device coating technology. Read more...

StrixNB™ is the company's trademark for the oral care market, which contains a portfolio of oral care products. Read more...

KBI Antibacterial Disinfectant is the company's product line for the surface disinfectants market, which are antibiofilm-antimicrobial surface disinfectant solutions. Read more...

What's New


StrixNB Logo

Click here to learn more about StrixNB™ Pet Oral Care Water Additive


Read more about Kane's latest product - KBI Antibacterial Disinfectant (KBI).KBI contains a unique, patented, antimicrobial-antibiofilm combination comprised of Chlorhexidine (CHX) and Sodium Metaperiodate (SMP).

White Papers


KBI Antibacterial Hard Surface Disinfectant